Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications.
about
Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditionsMatrix metalloproteinase 1: role in sarcoma biologyBiophytum sensitivum (L.) DC inhibits tumor cell invasion and metastasis through a mechanism involving regulation of MMPs, prolyl hydroxylase, lysyl oxidase, nm23, ERK-1, ERK-2, STAT-1, and proinflammatory cytokine gene expression in metastatic lungCysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancerAssociation of matrix metalloproteinase-3 -1171(5A>6A) polymorphism with cancer risk: a meta-analysis of 41 studies.Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinomaMatrix metalloproteinases and their inhibitors in tumour growth and invasion.Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma.Dissemination of T cell lymphoma to target organs: a post-homing event implicating ICAM-1 and matrix metalloproteinases.Carnosic acid inhibits the epithelial-mesenchymal transition in B16F10 melanoma cells: a possible mechanism for the inhibition of cell migration.Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases.Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasisCellular activation of the self-quenched fluorescent reporter probe in tumor microenvironment.Metvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity.Do premenopausal hypothyroid women on levothyroxine therapy need bone status monitoring?Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression.The mechanisms by which polyamines accelerate tumor spread.Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach.Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinomaArsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy.The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin.Correlations of polymorphisms in matrix metalloproteinase-1, -2, and -7 promoters to susceptibility to malignant gliomasA Novel Chemically Modified Curcumin "Normalizes" Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial StudiesPeptide-based selective inhibitors of matrix metalloproteinase-mediated activities4-HPR impairs bladder cancer cell migration and invasion by interfering with the Wnt5a/JNK and Wnt5a/MMP-2 signaling pathwaysEpidermal development and wound healing in matrix metalloproteinase 13-deficient mice.Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion.Recruitment and retention: factors that affect pericyte migration.Liver X receptor α (LXRα) promoted invasion and EMT of gastric cancer cells by regulation of NF-κB activity.Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.Maclurin suppresses migration and invasion of human non-small-cell lung cancer cells via anti-oxidative activity and inhibition of the Src/FAK-ERK-β-catenin pathway.Dietary gallic acid and anthocyanin cytotoxicity on human fibrosarcoma HT1080 cells. A study on the mode of action.PF-3758309, p21-activated kinase 4 inhibitor, suppresses migration and invasion of A549 human lung cancer cells via regulation of CREB, NF-κB, and β-catenin signalings.Progress towards water-soluble triazole-based selective MMP-2 inhibitors.Anti-metastatic effect of cantharidin in A549 human lung cancer cells.Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases.High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells.Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1.Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.
P2860
Q24313031-A7C1FF50-DB46-44F5-A315-5A513C311DA2Q27315973-FD96CAEA-FBE9-4545-8CC5-D7B925D016CEQ28269683-18B0A59C-037A-47EC-BAA5-8D9317922DB4Q28482436-4D4143CC-D715-4E86-9786-ECD419605A2EQ31149571-6A423E68-06A7-429E-9001-AD8F8F5E8502Q33473894-C3F34F87-220D-409E-939A-EA418F1A919AQ33603385-FDDD0094-88AB-4730-A88A-3A308B917D27Q33643722-8F7D600C-E0C5-4963-A9BD-706F8E0C638DQ33647926-B9B99F7B-7E04-480B-9D86-D6B184D00735Q34072491-F0E29706-4B42-4E91-9B5E-81419247DF44Q34250119-30E23DDC-875E-41B0-8225-B2618897B57DQ34391559-7CB59891-DC77-4948-B163-169D1775BB19Q34929009-9EAD93BA-576A-4659-9C8F-FAE443583B91Q35011927-0A3825A3-76D7-4398-A990-1359B328E5BEQ35184872-584F7D2F-7A1A-4E55-87F0-B0DEE335C4FBQ35274707-6102A523-A53C-49F1-A5F3-F4F9C2614003Q35505118-E5ADE6A8-99D1-47F8-93A9-8DCF2189031EQ36066182-C698E11D-2B53-4F19-8559-12762C00C26CQ36157337-1303D89D-84DF-45C1-BC70-C31259EAB2C1Q36165416-38B6A0E8-B4CB-429B-8C5F-F205F0E640B4Q36255141-8B6FBDDB-E054-4F63-B5DF-1CD291121358Q36326164-DDF423A0-0FAC-4E91-BB7B-68C3CC3B509EQ36715291-140577A3-B610-4FB7-9FF4-8F94B79F3CDBQ36840741-190A4C09-145E-4EB8-94A8-22D874CB9C63Q36919032-0EAC4E1F-59A3-4C67-801D-D019AABB86D2Q37204724-83C30F6F-D351-4926-8A63-C1661091AD0AQ37399542-C9583EF3-9FCF-4408-98E4-3828AF201B87Q37495285-4B3B8137-10D6-47E0-9D76-A708C57801ABQ38126398-2301D710-DD82-4604-917A-A56C672CEAABQ38721169-31A95591-84E6-4690-B16A-821DB8E05F68Q38851330-FBC68A05-22E1-4668-BB6F-1BBD28FE1240Q38915648-2D3D3E89-3118-4E7D-A1E0-1F252DAB385EQ39035267-6CCABD16-10EF-4EB8-9EE7-86B512847D80Q39040458-7662AC5F-BDA8-432F-BAF7-6B2431437E24Q39103154-D7B9EB38-49C8-4A2A-A1D9-1F3999B4EAB8Q39189524-71DA32D0-52D7-4867-B8AD-2489F7D8BCA5Q39704776-6AEB0997-E87D-43CD-8164-E51227A8FCB5Q40719128-75DC9CF7-E5FC-44A8-BEF8-449587037E6FQ40862510-7D33562F-2199-4DCA-8BC8-EB9D0C165BCAQ40982613-1D82C884-E5F1-48C9-8B0B-9217E5AFF90B
P2860
Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Matrix metalloproteinases as s ...... ion: therapeutic implications.
@en
type
label
Matrix metalloproteinases as s ...... ion: therapeutic implications.
@en
prefLabel
Matrix metalloproteinases as s ...... ion: therapeutic implications.
@en
P2093
P1433
P1476
Matrix metalloproteinases as s ...... ion: therapeutic implications.
@en
P2093
Bellocq JP
Chenard MP
P304
P356
10.1016/S0945-053X(97)90028-7
P577
1997-03-01T00:00:00Z